Evidence in the eye of the beholder: about probiotics and VAP prevention

Stijn Blot^{1

2}, Antonio Torres^{3

4}, Bruno Francois⁵

Affiliations

¹ Department of Internal Medicine, Ghent University, De Pintelaan 185, 9000, Ghent, Belgium. stijn.blot@ugent.be.
² Burns Trauma and Critical Care Research Centre, The University of Queensland, Brisbane, Australia. stijn.blot@ugent.be.
³ Pulmonary Intensive Care Unit, Respiratory Institute, Hospital Clínic of Barcelona, Barcelona, Spain.
⁴ IDIBAPS and CIBERES, Barcelona, Spain.
⁵ Inserm CIC 1435, Inserm UMR 1092 and Reanimation Polyvalente, CHU Limoges, Limoges, France.

Editorial

Stijn Blot et al. Intensive Care Med. 2016 Jul.

. 2016 Jul;42(7):1182-4.

doi: 10.1007/s00134-016-4353-0. Epub 2016 Apr 13.

Stijn Blot^{1

2}, Antonio Torres^{3

4}, Bruno Francois⁵

¹ Department of Internal Medicine, Ghent University, De Pintelaan 185, 9000, Ghent, Belgium. stijn.blot@ugent.be.
² Burns Trauma and Critical Care Research Centre, The University of Queensland, Brisbane, Australia. stijn.blot@ugent.be.
³ Pulmonary Intensive Care Unit, Respiratory Institute, Hospital Clínic of Barcelona, Barcelona, Spain.
⁴ IDIBAPS and CIBERES, Barcelona, Spain.
⁵ Inserm CIC 1435, Inserm UMR 1092 and Reanimation Polyvalente, CHU Limoges, Limoges, France.

No abstract available

Cited by

Ventilation-associated pneumonia and probiotics: many clues do not make evidence. Response to comments by Colombo and Codazzi.
Zeng J, Wang CT. Zeng J, et al. Intensive Care Med. 2016 Sep;42(9):1513-4. doi: 10.1007/s00134-016-4395-3. Epub 2016 Jul 28. Intensive Care Med. 2016. PMID: 27468844 No abstract available.